Ibrushil 140s
Ibrushil is a small molecule drug that binds permanently toa protein, Bruton tyrosine kinase (BTK), which is important in B cells. Ibrushilis used to treat B cell cancers like mantle cell lymphoma, chronic lymphocyticleukemia, and Waldenstr ms macroglobulinemia.
Uses:
Mantle-cell lymphoma and blood cancer(chronic lymphocytic leukemia)
Specification
Brand name | Ibrushil |
Active substance | Ibrutinib |
Strength | 140mg |
Category | Anti Cancer |
Manufacturer | Shilpa Medicare Ltd |
Packaging | 120 Capsules |
Product form | Capsules |